Stoke Therapeutics
STOK
#5106
Rank
ยฃ1.36 B
Marketcap
ยฃ22.00
Share price
-1.18%
Change (1 day)
125.68%
Change (1 year)

Revenue for Stoke Therapeutics (STOK)

Revenue in 2026 (TTM): ยฃ23.71 Million

According to Stoke Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ24.08 Million. In 2025 the company made a revenue of ยฃ0.13 Billion an increase over the revenue in the year 2024 that were of ยฃ29.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Stoke Therapeutics from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ23.71 M-82.68%
2025 ยฃ0.13 B370.11%
2024 ยฃ29.12 M322.63%
2023 ยฃ6.89 M-32.78%
2022 ยฃ10.25 M
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA